IPR v. Ex Parte Reexam Strategy Considerations
February 7, 2024, 7:16 AM
Looking forward to presenting at the AIPLA IP Practice in Japan Mid-Winter Program in Houston, TX next week!
I will be discussing the strategic considerations for Inter Partes Review (IPR) versus Ex Parte Reexamination, including:
- The procedural differences between IPR and Ex Parte Reexamination and associated statistics
- The circumstances when one may be preferable over the other
- The effects of timing and estoppel in parallel litigations
My colleague, Jason Murata, another partner in Axinn’s Intellectual Property group, will be covering, “Recent Developments in the Generic Pharma Industry in the U.S.”

To subscribe to our publications, click here.
News & Insights
News & Insights
DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead
Speaking Engagement
Antitrust
Informa Antitrust Midwest 2026
Speaking Engagement
Antitrust
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2026
Sponsorship
What’s Up? Enforcement Updates From the Middle East and Africa
Podcast
Antitrust
AHLA Annual Meeting & In-House Counsel Program
Sponsorship
Antitrust
Lexology In-Depth: Intellectual Property and Antitrust (2026)
Byline Articles
Intellectual Property
Tracking The Rare 'Quick Look' Win In FTC's Zillow-Redfin Suit
Byline Articles
Antitrust
Gleiss Lutz Annual Antitrust Law Conference
Speaking Engagement
Antitrust
What Top Law Firms Say New Lawyers Need in the AI Era
Media Mentions
What’s the Role of Communications Strategy in M&A? How Public Affairs Impacts Antitrust
Podcast
Antitrust